Ewa, LLC Autolus Therapeutics PLC Transaction History
Ewa, LLC
- $241 Billion
- Q2 2024
A detailed history of Ewa, LLC transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Ewa, LLC holds 17,738 shares of AUTL stock, worth $63,856. This represents 0.03% of its overall portfolio holdings.
Number of Shares
17,738
Previous 24,300
27.0%
Holding current value
$63,856
Previous $97 Million
21.52%
% of portfolio
0.03%
Previous 0.04%
Shares
4 transactions
Others Institutions Holding AUTL
# of Institutions
114Shares Held
167MCall Options Held
34.2KPut Options Held
19.5K-
Syncona Portfolio LTD Guernsey, Channel Islands, X021.3MShares$76.8 Million86.45% of portfolio
-
Blackstone Inc New York, NY20.5MShares$73.7 Million0.31% of portfolio
-
Wellington Management Group LLP Boston, MA17.9MShares$64.4 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT15.3MShares$55 Million1.74% of portfolio
-
Avoro Capital Advisors LLC New York, NY12.3MShares$44.4 Million0.59% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $327M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...